What we do

IXICO provides neuroscience expertise, regulatory oversight, and global operations to deliver imaging and digital biomarker analytical services for clinical development

Early Phase Clinical Development

Early Phase

We have extensive experience in definition and delivery of early-phase clinical development, where rigorous patient safety screening runs hand-in-hand with flexibility around trial design and data analytics.

Early Phase

Late Phase Clinical Development

Late Phase

IXICO's global network of over 2,000 imaging sites and bespoke TrialTracker platform ensure that large-scale trials can be set up quickly and efficiently to deliver data that is as reliable as it is regulatory compliant.

Late Phase

Post-Marketing

IXICO's expertise in data analytics makes us a perfect partner for continued assessment once a drug is licensed. IXICO understands the challenges of extended longitudinal studies, and the importance of monitoring patient safety and drug utilisation for ongoing optimisation of patient pathways.

Post-Marketing

Consultancy

With many years of experience in supporting regulatory-compliant clinical research, we often work with clients on the selection and use of neuroimaging and digital biomarkers - whether directly with your own teams or as members of collaborative consortia.

Consultancy